Please click here to check who's online and chat with them.

Find Verified Public Seats Suppliers, Manufacturers and Wholesalers

Top Supplier Cities : London   Montreal   Toronto  
Aug-06-20
Supplier From Montreal, Quebec, Canada
 
Polyester in bales from car seat industry, post-industrial.
65% white, and 35% black.
Price: $280 CNF without DTHC to all major ports
Aug-09-05
Supplier From Montreal, Quebec, Canada
Sep-25-06
Supplier From Montreal, Quebec, Canada
Mar-18-21
Supplier From Montreal, Qc, Canada
 
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety

Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly

The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.

PRODUCT INFORMATION:

Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay

CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
Mar-19-24
Supplier From Montreal, Qc, Canada
5 Public Seats Suppliers
Short on time? Let Public Seats sellers contact you.